Success Metrics

Clinical Success Rate
73.3%

Based on 11 completed trials

Completion Rate
73%(11/15)
Active Trials
1(5%)
Results Posted
64%(7 trials)
Terminated
4(18%)

Phase Distribution

Ph phase_2
8
36%
Ph phase_1
3
14%
Ph phase_4
7
32%
Ph phase_3
1
5%
Ph not_applicable
3
14%

Phase Distribution

3

Early Stage

8

Mid Stage

8

Late Stage

Phase Distribution22 total trials
Phase 1Safety & dosage
3(13.6%)
Phase 2Efficacy & side effects
8(36.4%)
Phase 3Large-scale testing
1(4.5%)
Phase 4Post-market surveillance
7(31.8%)
N/ANon-phased studies
3(13.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

68.8%

11 of 16 finished

Non-Completion Rate

31.3%

5 ended early

Currently Active

1

trials recruiting

Total Trials

22

all time

Status Distribution
Active(2)
Completed(11)
Terminated(5)
Other(4)

Detailed Status

Completed11
Terminated4
unknown4
Withdrawn1
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
22
Active
1
Success Rate
73.3%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (13.6%)
Phase 28 (36.4%)
Phase 31 (4.5%)
Phase 47 (31.8%)
N/A3 (13.6%)

Trials by Status

terminated418%
completed1150%
unknown418%
withdrawn15%
not_yet_recruiting15%
recruiting15%

Recent Activity

Clinical Trials (22)

Showing 20 of 22 trialsScroll for more
NCT07151612Phase 4

The Development of New Functions of Esculin and Digitalis Glycosides Eye Drops: A Study on the Treatment of Presbyopia

Completed
NCT07491146Phase 2

Phase II Clinical Study of the Efficacy and Safety of HSK55718 in the Treatment of Abdominal Postoperative Pain

Not Yet Recruiting
NCT05208125Phase 1

A Phase I, Randomized, Double-Blind, Placebo-Controlled Safety, Tolerability and Immunogenicity Study of Candidate HIV-1 Vaccines ChAdOx1.HTI and MVA.HTI With Recombinant HIV-1 Envelope Protein ConM SOSIP.v7 gp140 Vaccine, Adjuvanted With MPLA Liposomes in ART-Suppressed HIV-1 Positive Individuals

Completed
NCT05818826Phase 2

Early Versus Conventional Cessation of Hydrocortisone in Septic Shock

Recruiting
NCT01531803Phase 4

Safety Study of Kedbumin 25% Versus Normal Saline in the Treatment of Post-Surgical Hypovolemia in Pediatric Patients

Terminated
NCT03066778Phase 3

A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604)

Completed
NCT02591251Phase 2

Povidone-iodine Versus Normal Saline Solution in Vaginal Cleansing in Laparoscopy

Completed
NCT05132972Phase 2

Allogenic UCMSCs as Adjuvant Therapy for Severe COVID-19 Patients

Unknown
NCT03756220Phase 2

Ascorbic Acid and Thiamine Effect in Septic Shock

Completed
NCT02326675Not Applicable

Cryotherapy in the Prevention of Chemotherapy-Induced Mucositis in Stem Cell Transplant

Terminated
NCT03542617Phase 4

Effect of Preoperative Intravenous Dexamethasone on Postoperative Pain After Primary Total Hip Arthroplasty

Unknown
NCT01866943Phase 2

Role of Topical Tranexamic Acid in Total Hip Arthroplasty

Terminated
NCT02322892Phase 2

Thiamine as an Adjunctive Therapy in Cardiac Surgery

Completed
NCT02785133Not Applicable

Safety and Feasibility of Polychromatic Light Emitting Diode for Peripheral Catheter Illumination During Peripheral Intravenous Delivery of Normal Saline

Completed
NCT02760459Phase 4

Effects of Perioperative Intravenous Dexamethasone on the Severity of Persistent Postsurgical Pain After Total Knee Arthroplasty : A Prospective, Randomized, Double-blind, Placebo-controlled Trial

Unknown
NCT01250886Phase 1

Acid-base Balance in Patients Undergoing Colonoscopy

Unknown
NCT00288600Phase 4

Efficacy of High-dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease

Completed
NCT00729274Not Applicable

HYPERTONIC SALINE IN ACUTE VIRAL BRONCHIOLITIS: A RANDOMIZED CLINICAL TRIAL

Withdrawn
NCT01498003Phase 4

Tirofiban in Stenting for Long Coronary Lesion

Completed
NCT01847222Phase 1

An Assessment of the Safety and Pharmacokinetics of Ascending Doses of SANGUINATE™ in Healthy Volunteers.

Terminated

Drug Details

Intervention Type
DRUG
Total Trials
22